SEC Form 4 · accession 0001140361-17-003952
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Slayton
Officer — Principal Accounting Officer
Period of report
Jan 30, 2017
Accepted (ET)
Feb 1, 2017 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2017 | F | 95 | $55.85 | D | 7,422 | D | |
| Common Stock | Jan 31, 2017 | F | 82 | $55.95 | D | 7,340 | D | |
| Common StockF1 | holding | — | — | — | 7,517 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Increase from last filing represents 448 shares acquired under the Vascular Solutions Stock Purchase Plan for the period ending April 30, 2016 at $18.05 per share; and 276 shares acquired under the Plan for the period ending October 31, 2016 at $29.62 per share.